Letter: Treatment of strongyloidiasis.
D002648:Child; D006801:Humans; D007223:Infant; D011774:Pyrvinium Compounds / Q000627:therapeutic use*; D013322:Strongyloidiasis / Q000188:drug therapy*; D013827:Thiabendazole / Q000627:therapeutic use*
D011774:Pyrvinium Compounds; D013827:Thiabendazole